ArticleHarm reduction journal2011
US smokers' reactions to a brief trial of oral nicotine products.
Article in Harm reduction journal, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2015Pooled it
- A longitudinal, naturalistic study of U.S. smokers' trial and adoption of snus.Addictive behaviors · 2016Trial
- Randomised clinical trial of snus versus medicinal nicotine among smokers interested in product switching.Tobacco control · 2016Trial
- The impact of free trial acceptance on demand for alternative nicotine products: evidence from experimental auctions.Harm reduction journal · 2015Trial
- Public education about the relative harm of tobacco products: an intervention for tobacco control professionals.Tobacco control · 2014Trial
- Brief, instructional smokeless tobacco use among cigarette smokers who do not intend to quit: a pilot randomized clinical trial.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2014Trial
- The impact of product information and trials on demand for smokeless tobacco and cigarettes: evidence from experimental auctions.Preventive medicine · 2014Trial
- Estimating demand for alternatives to cigarettes with online purchase tasks.American journal of health behavior · 2014Trial
- A reduced exposure heated tobacco product was introduced then abruptly taken off United States shelves: results from a tobacco harm reduction natural experiment.Harm reduction journal · 2024Article
- Perceptions of Oral Nicotine Pouches on Reddit: Observational Study.Journal of medical Internet research · 2022Observational
- Intention to purchase alternative tobacco products as a function of smoking status and responses to advertising, packaging, and sensory experiences.Addictive behaviors · 2022Article
- Adult interest in using a hypothetical modified risk tobacco product: findings from wave 1 of the Population Assessment of Tobacco and Health Study (2013-14).Addiction (Abingdon, England) · 2018Article
- Perceptions of Snus Among US Adult Smokers Given Free Product.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2017Article
- Evaluation of modified risk claim advertising formats for Camel Snus.Health education journal · 2017Article
- Exploratory survey study of long-term users of nicotine replacement therapy in Danish consumers.Harm reduction journal · 2015Article
- Intention to switch to smokeless tobacco use among South African smokers: results from the 2007 South African Social Attitudes Survey.PloS one · 2014Article
- Subjective responses to oral tobacco products: scale validation.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2013Article
- Is snus the same as dip? Smokers' perceptions of new smokeless tobacco advertising.Tobacco control · 2013Article
- Young adults' favorable perceptions of snus, dissolvable tobacco products, and electronic cigarettes: findings from a focus group study.American journal of public health · 2012Article
- Effects of a Fact Sheet on beliefs about the harmfulness of alternative nicotine delivery systems compared with cigarettes.Harm reduction journal · 2012Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundIt has been suggested that cigarette smokers will switch to alternative oral nicotine delivery products to reduce their health risks if informed of the relative risk difference. However, it is important to assess how smokers are likely to use cigarette alternatives before making predictions about their potential to promote individual or population harm reduction.
objectivesThis study examines smokers' interest in using a smokeless tobacco or a nicotine replacement product as a substitute for their cigarettes.
methodsThe study included 67 adult cigarette smokers, not currently interested in quitting, who were given an opportunity to sample four alternative oral nicotine products: 1) Camel Snus, 2) Marlboro Snus, 3) Stonewall dissolvable tobacco tablets, and 4) Commit nicotine lozenges. At visit 1, subjects were presented information about the relative benefits/risks of oral nicotine delivery compared to cigarettes. At visit 2, subjects were given a supply of each of the four products to sample at home for a week. At visit 3, subjects received a one-week supply of their preferred product to see if using such products reduced or eliminated cigarette use.
resultsAfter multiple product sampling, participants preferred the Commit lozenges over the three smokeless tobacco products (p = 0.011). Following the one week single-product trial experience, GEE models controlling for gender, age, level of education, baseline cigarettes use, and alternative product chosen, indicated a significant decline in cigarettes smoked per day across one week of single-product sampling (p < 0.01, from 11.8 to 8.7 cigarettes per day), but no change in alternative product use (approximately 4.5 units per day). Biomarkers of exposure showed no change in cotinine, but a 19% reduction in exhaled CO (p < 0.001).
conclusionsFindings from this study show that smokers, who are currently unwilling to make a quit attempt, may be willing to use alternative products in the short term as a temporary substitute for smoking. However, this use is more likely to be for partial substitution (i.e. they will continue to smoke, albeit at a lower rate) rather than complete substitution. Of the various substitutes offered, smokers were more willing to use a nicotine replacement product over a tobacco-based product.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.